Encompass Health Overview
Encompass Health Target Price
Analysts' 12-month price predictions for EHC.
Get informed when a big investor buys or sells
+ FollowShare Price
$99.9
Average Target Price
$146.00
46.1% upside
46.1% upside2 analysts in the last 4 months
High: $152 | Low: $140
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-05-22 | Leerink PartnersWhit Mayo | $152 | 52.2% upside |  |
| 2026-05-05 | Barclays | $140 | 40.1% upside | |
| 2026-02-06 | Barclays | $153 | 53.2% upside | |
| 2025-10-30 | BarclaysAndrew Mok | $150 | 50.2% upside | |
| 2025-10-02 | UBS | $150 | 50.2% upside | |
| 2025-08-14 | Truist FinancialDavid MacDonald | $140 | 40.1% upside | |
| 2025-04-28 | RBC Capital | $125 | 25.1% upside | |
| 2024-09-26 | RBC CapitalBen Hendrix | $105 | 5.1% upside | |
| 2024-09-25 | UBSAJ Rice | $110 | 10.1% upside | |
| 2024-05-22 | RBC CapitalFrank Morgan | $95 |  4.9% downside | |
| 2024-04-25 | Mizuho SecuritiesAnn Hynes | $95 | 4.9% downside | |
| 2024-03-28 | BarclaysAndrew Mok | $101 | 1.1% upside | |
| 2022-05-03 | RBC Capital | $85 | 14.9% downside | |
| 2022-05-02 | Raymond James | $85 | 14.9% downside | |
| 2022-04-29 | Credit Suisse | $83 | 16.9% downside | |
| 2021-04-29 | StephensScott Fidel | $100 | 0.1% upside | |